Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance

Oncogene. 2023 Oct;42(42):3157-3158. doi: 10.1038/s41388-023-02832-1.

Authors

Affiliations

¹ Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina.
² Departamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco, Chile.
³ Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
⁴ Laboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina. patriciaelizalde@ibyme.conicet.gov.ar.

^# Contributed equally.

PMID: 37684410
DOI: 10.1038/s41388-023-02832-1

No abstract available

Publication types

Published Erratum